Christine Gigliuto
Internal Medicine · Toms River, NJNPI 1952374266
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $247 and has fallen 67.2% since, to $81 in 2025.
Across 43 payments — averaging $15.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$120
- AstraZeneca$109
- Lilly USA, LLC$73
- Amarin Pharma, Inc.$40
- Pfizer$39
- GSK$27
- plus $240 from 16 others
What the payments were for
- Food & beverage$648100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 9 | $120 |
| AstraZeneca | 3 | $109 |
| Lilly USA, LLC | 5 | $73 |
| Amarin Pharma, Inc. | 3 | $40 |
| Pfizer | 3 | $39 |
| GSK | 2 | $27 |
| AbbVie | 2 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Corcept Therapeutics | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Bausch Health US, LLC | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
| Optinose US, Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 2 | $12 |
| Boehringer Ingelheim | 1 | $12 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Currax Pharmaceuticals LLC | 1 | $12 |
How this compares
$648 in reported general payments places this provider in the 60th percentile of 4,032 internal medicine providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 21 | $223 |
| Lisinopril | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Toms River
- Samir JainToms River$32K
- Akshay PatelToms River$27K
- Ralph GuarinoToms River$26K
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.